Novartis India Limited (NOVARTIND.BO)
INR 998.85
(-1.78%)
INR 998.85
(-1.78%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.48 Billion | 448 Million | 386.7 Million | -692.1 Million | -231.4 Million | -1.94 Billion |
| Net Income | 851.9 Million | 1.15 Billion | -38.2 Million | 400.4 Million | 286.4 Million | 857.7 Million |
| Depreciation & Amortization | 26.1 Million | 60.6 Million | 96.5 Million | 121.6 Million | 131.4 Million | 31.8 Million |
| Deferred income taxes | - | 3.7 Million | -183.5 Million | -399.5 Million | -372.3 Million | -766.7 Million |
| Stock-based compensation | 2.5 Million | 3.8 Million | 18.5 Million | 17.4 Million | 36.8 Million | -7.6 Million |
| Change in working capital | 90.4 Million | -240 Million | 667.2 Million | -690.8 Million | -18.5 Million | -1.61 Billion |
| Other non-cash items | 498.2 Million | -533.9 Million | -173.8 Million | -141.2 Million | -295.2 Million | -440.4 Million |
| Investing Cash Flow | -15.6 Million | -1.53 Billion | 870.4 Million | 951.6 Million | 559.1 Million | 2.74 Billion |
| Investments in PPE | - | -3.1 Million | -5 Million | -900 Thousand | -10 Million | -140.6 Million |
| Acquisitions | 32.7 Million | 39.4 Million | - | 46.8 Million | 600 Thousand | 302.1 Million |
| Investment purchases | -10.4 Billion | -11.41 Billion | -17.51 Billion | - | 205.5 Million | -1.69 Billion |
| Sales/Maturities of investments | 10.35 Billion | 9.64 Billion | 18.23 Billion | 697.9 Million | 181.5 Million | 2.13 Billion |
| Other Investing Activities | 32.7 Million | 199.8 Million | 155.4 Million | 207.8 Million | 181.5 Million | 2.13 Billion |
| Financing Cash Flow | -1.2 Billion | -304.8 Million | -356.3 Million | -368 Million | -414.1 Million | -298.2 Million |
| Debt repayment | -37 Million | -57.4 Million | -109 Million | -120.3 Million | -52.5 Million | - |
| Dividends payments | -1.17 Billion | -246.9 Million | -246.9 Million | -246.9 Million | -297.7 Million | -247.4 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -100 Thousand | -500 Thousand | -400 Thousand | -800 Thousand | -114.7 Million | -50.8 Million |
| Accounts receivables | -53.4 Million | 80.3 Million | -42 Million | -9.2 Million | 81.4 Million | -24.2 Million |
| Accounts payables | 21.2 Million | -100.2 Million | 148.3 Million | -173.8 Million | -220.9 Million | -135.6 Million |
| Inventory | 98.6 Million | 23.5 Million | -91.2 Million | 107.3 Million | 18.3 Million | -39.5 Million |
| Other working capital | 24 Million | -243.6 Million | 652.1 Million | -615.1 Million | 102.7 Million | -1.41 Billion |
| Cash at beginning of period | 209.4 Million | 1.58 Billion | 682.7 Million | 791.2 Million | 877.6 Million | 376.3 Million |
| Cash at end of period | 5.96 Billion | 194.2 Million | 1.58 Billion | 682.7 Million | 791.2 Million | 877.6 Million |
| Capital Expenditure | - | -3.1 Million | -5 Million | -900 Thousand | -10 Million | -140.6 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.75 Billion | -1.38 Billion | 900.8 Million | -108.5 Million | -86.4 Million | 501.3 Million |
| Free Cash Flow | 1.48 Billion | 444.9 Million | 381.7 Million | -693 Million | -241.4 Million | -2.08 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 257.39 Million | 851.9 Million | 146.8 Million | 265.7 Million | 236.8 Million | 202.6 Million |
| Depreciation & Amortization | - | 26.1 Million | - | 2.6 Million | 6.5 Million | 15.6 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 2.5 Million | 2.5 Million | - | - | - |
| Change in working capital | - | 90.4 Million | - | - | - | - |
| Other non-cash items | -257.39 Million | 498.2 Million | -149.3 Million | -265.7 Million | -236.8 Million | -202.6 Million |
| Investing Cash Flow | - | -15.6 Million | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | 32.7 Million | - | - | - | - |
| Investment purchases | - | -10.4 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 10.35 Billion | - | - | - | - |
| Other Investing Activities | - | 32.7 Million | - | - | - | - |
| Financing Cash Flow | - | -1.2 Billion | - | - | - | - |
| Debt repayment | - | -37 Million | - | - | - | - |
| Dividends payments | - | -1.17 Billion | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -100 Thousand | - | - | - | - |
| Accounts receivables | - | -53.4 Million | - | - | - | - |
| Accounts payables | - | 21.2 Million | - | - | - | - |
| Inventory | - | 98.6 Million | - | - | - | - |
| Other working capital | - | 24 Million | - | - | - | - |
| Cash at beginning of period | - | 209.4 Million | - | 4.9 Billion | 4.66 Billion | 209.4 Million |
| Cash at end of period | - | 5.96 Billion | - | 265.7 Million | 4.9 Billion | 202.6 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 5.75 Billion | - | -4.63 Billion | 236.8 Million | -6.8 Million |
| Free Cash Flow | - | 1.48 Billion | - | 265.7 Million | 236.8 Million | 202.6 Million |
5236
JARU
298020
210980
605056
HDN